Exozymes - About the company
Exozymes is a funded company based in Monrovia (United States), founded in 2019 by Anthony Digiandomenico, Jim Bowie, James Bowie, James Bowie Ph.D. and Paul Opgenorth. It operates as a Developer of exozyme biosolutions for nutraceutical, medicine, and biofuel markets. Exozymes has raised an undisclosed amount in funding. The company has 53 active competitors, including 5 funded and 4 that have exited. Its top competitors include companies like BRAIN, Novonesis and Anodyne Chemistries.
Company Details
Developer of exozyme biosolutions for nutraceutical, medicine, and biofuel markets. The company focuses on engineering advanced enzymes using artificial intelligence for chemical production. It transforms feedstocks into small-molecule chemicals, including active pharmaceutical ingredients. The technology aims to replace traditional chemical production methods with sustainable alternatives.
- Website
- exozymes.com
- Email ID
- *****@exozymes.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2019
Location
Monrovia, United States
Stage
Funding Raised
Latest Funding Round
Ranked
5th among 53 active competitors
Employee Count
38 as on Sep 30, 2026
Sign up to download Exozymes' company profile
Exozymes's funding and investors
Exozymes has raised funding over 3 rounds. Its first funding round was on Mar 26, 2025. Its latest funding round was a Grant (prize money) round on Jul 02, 2025 for $*****. 1 investor participated in its latest round. Exozymes has 2 institutional investors.
Here is the list of recent funding rounds of Exozymes:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 02, 2025 | 5289231 | Grant (prize money) | 1320468 | 7568433 | 4994332 | 8058722 |
May 06, 2025 | 7829463 | Grant (prize money) | 2765450 | 7109274 | 2226936 | |
Mar 26, 2025 | 6309622 | Grant (prize money) | 8009106 | 9713669 | 3124615 |
View details of Exozymes's funding rounds and investors
Exozymes' founders and board of directors
Founder? Claim ProfileThe founders of Exozymes are Anthony Digiandomenico, Jim Bowie, James Bowie, James Bowie Ph.D. and Paul Opgenorth.
Here are the details of Exozymes' key team members:
- Anthony Digiandomenico: Co-Founder & Director & Audit Chairman of Exozymes and founder of 2 other companies, Public Ventures and MDB Capital. Contact Info: 2 email addresses
- Jim Bowie: Co-Founder of Exozymes and founder of 1 other company. Contact Info: 2 email addresses
- James Bowie: Co-Founder of Exozymes. Contact Info: 1 email address
- James Bowie Ph.D.: Co-Founder of Exozymes. Contact Info: 1 email address
- Paul Opgenorth: Co-Founder of Exozymes. Contact Info: 1 email address
View details of Exozymes's Founder profiles and Board Members
Exozymes' employee count trend
Exozymes has 38 employees as of Sep 26. Here is Exozymes's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Exozymes's Competitors and alternates
Top competitors of Exozymes include BRAIN, Novonesis and Anodyne Chemistries. Here is the list of Top 10 competitors of Exozymes, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developr of bio-based products and natural compounds for biotechnological solutions | $5.38M | 68/100 | ||
2nd | Company focuses on creating biosolutions | - | 55/100 | ||
3rd | Anodyne Chemistries 2021, Vancouver (Canada), Seed | Provider of immobilized enzyme complexes for green chemical production | $1M | 48/100 | |
4th | Provider of a platform focused on enzymatic recycling processes | - | 48/100 | ||
5th | Exozymes 2019, Monrovia (United States), Funding Raised | Developer of exozyme biosolutions for nutraceutical, medicine, and biofuel markets | - | 49/100 | |
6th | Infinita Biotech 2015, Vadodara (India), Unfunded | Provider of enzymatic solutions for various industries | - | - | 40/100 |
7th | Quantumzyme 2016, Bengaluru (India), Seed | Developer of computational tools for engineering enzymes for industrial applications | - | 38/100 | |
8th | Provider of water treatment technology | - | 34/100 | ||
9th | ![]() Neu Elements Pvt Ltd Bengaluru (India), Unfunded | Developer of enzyme solutions for industrial applications, including grain processing | - | - | 33/100 |
10th | Provider of eco-friendly biotech solutions for sustainable growth | - | - | 33/100 |
Looking for more details on Exozymes's competitors? Click here to see the top ones
Exozymes's Investments and acquisitions
Exozymes has made no investments or acquisitions yet.
Reports related to Exozymes
Here is the latest report on Exozymes's sector:
News related to Exozymes
Media has covered Exozymes for a total of 17 events in the last 1 year, 10 of them have been about company updates and 2 about partnerships.
•
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCTNewswire•Sep 08, 2026•Exozymes, Curia
•
eXoZymes Reports Second Quarter 2026 Results and Provides Business UpdateNewswire•Aug 21, 2026•Exozymes
•
eXoZymes Announces Significant Improvements to NCT Manufacturing ProcessNewswire•Aug 19, 2026•Exozymes
•
eXoZymes Selected for DOE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free BiomanufacturingNewswire•Jul 24, 2026•Exozymes
•
Rocket Doctor AI Subsidiary Treatment.com Secures Year 2 NIH Funding for AI Family Health History ToolGlobeNewswire•Jun 16, 2026•Rocket Doctor, NIH, Treatment, Exozymes
•
eXoZymes Inc. Prices Public Offering of Common Stock and WarrantsNewswire•Jun 08, 2026•Exozymes, MDB Capital
•
eXoZymes Announces Graduation from Shell GameChanger Accelerator Powered by NLR ProgramNewswire•May 07, 2026•Exozymes
•
•
•
eXoZymes advances commercial readiness with profound production metrics on initial NCT pilot runNewswire•Jan 30, 2026•Exozymes
Are you a Founder ?
FAQs about Exozymes
Explore our recently published companies
- Syncopio - Germany based, 2026 founded, Unfunded company
- High Side RC - Unfunded company
- XO - London based, Unfunded company
- Cardinal Concierge - Overland Park based, 2021 founded, Unfunded company
- Silverback Coffee - New Zealand based, Unfunded company
- Greenest Feeds - United Kingdom based, 2024 founded, Unfunded company

